MOTS-c + SS-31 + NAD+
Educational overview. This protocol is not FDA-approved and represents a research-based approach to supporting mitochondrial function. Consultation with a qualified medical provider is required before pursuing any therapy.
The Cellular Energy Protocol targets mitochondrial function and metabolic efficiency. Mitochondria are the cellular structures responsible for producing ATP, the energy currency used by every cell in the body. The protocol approaches mitochondrial support through three distinct mechanisms: metabolic signaling between mitochondria and nucleus, stabilization of the inner mitochondrial membrane, and restoration of NAD+ cofactor availability.
MOTS-c is a mitochondrial-derived peptide — a signaling molecule produced by mitochondria that communicates metabolic status to the cell nucleus. Research has examined its effects on glucose metabolism, metabolic adaptation, and mitochondrial biogenesis. The proposed mechanism involves activation of AMPK, a cellular energy sensor that upregulates metabolic efficiency.
Studies in animal models and some human pharmacokinetic work suggest effects on metabolic markers and glucose handling. Direct clinical outcomes in humans are limited.
SS-31 (Szeto-Schiller-31) is a peptide designed to target the inner mitochondrial membrane, where it is proposed to stabilize cardiolipin, a phospholipid critical to optimal respiratory chain function. The mechanism is quite specific: protecting cardiolipin from oxidative damage and improving electron transport efficiency.
Research in cell cultures and animal models has shown effects on mitochondrial oxidative stress, ATP production, and metabolic efficiency. Human studies are sparse.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme required for multiple metabolic pathways, particularly those involving energy production and redox balance. NAD+ availability declines with age. Strategies to restore or maintain NAD+ have been studied for potential metabolic and anti-aging effects.
Oral supplementation with NAD+ precursors (NMN, NR) has shown effects on metabolic markers in some studies. The oral bioavailability of NAD+ itself is poor; other forms or delivery methods are used clinically.
These three compounds address mitochondrial function at different levels: signaling (MOTS-c), membrane integrity and efficiency (SS-31), and cofactor availability (NAD+). The hypothesis is that coordinated support across these levels produces greater metabolic efficiency and energy production than any single intervention.
This is mechanistically coherent but untested as a combination in humans.
Mitochondrial capacity correlates with exercise tolerance, recovery from exertion, and sustained mental effort. Individuals with poor mitochondrial function often report fatigue, reduced exercise capacity, and cognitive dulling. This protocol targets the proposed mechanism for these symptoms, though direct evidence that improving mitochondrial markers translates to symptom improvement in humans is limited.
Each component has research supporting its mechanism. That research is primarily in cell culture and animal models, with limited human studies. The human evidence that exists largely examines effects on biomarkers — metabolic markers, mitochondrial function markers — rather than clinical outcomes like sustained energy, exercise capacity, or cognitive performance.
The distinction is important: a compound that improves a mitochondrial marker may or may not improve how a person actually functions.
Mitochondrial function declines with age, and this decline is implicated in various age-related conditions. Restoring mitochondrial capacity in aging is a legitimate research interest. However, optimal mitochondrial function is first established and maintained through basic factors: regular training, particularly aerobic work and resistance exercise; adequate sleep; nutritional sufficiency; and metabolic health.
This protocol is most useful as an adjunct to those foundations rather than as a substitute for them.
This protocol is not FDA-approved. Mitochondrial function is foundational; exercise, sleep, and nutrition must be in place. Individual responses vary widely. Consult a qualified medical provider before pursuing any therapy.
